2004

Urban, J.D., E.A.Gay, and R.B. Mailman. 2004. Functional selectivity as a mechanism of action of newer atypical antipsychotic drugs. 34th Annual Neuroscience Meeting. October 23-27, 2004. San Diego, CA.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. (2004). Effects of prenatal exposure to perfluorooctane sulfonate on the developing lung in the rat. 43rd Annual Meeting of Society for Toxicology. March 21-25, 2004. Baltimore, MD.

Urban, J.D., E.A. Gay, and R.B. Mailman. 2004. Decreased neurological side-effects with aripiprazole: a result of functional selectivity of the D2 receptor? 43rd Annual Meeting of Society for Toxicology. March 21-25, 2004. Baltimore, MD.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. (2004). Perfluorooctane sulfonate (PFOS) alters lung development in the neonatal rat. Birth Defects Research, Part A, 70(5), 42.

2003

Haws, L. Combustion Risk Modeling and Assessment. Presented at the Texas Commission on Environmental Quality Workshop on Hazardous Waste Combustion. May 7, 2003. Austin, TX.

Perry, C.S. Process for development of protective concentration levels for remediation sites in Texas.Presented at Society for Environmental Toxicology and Chemistry (SETAC) meeting. November 9-13, 2003. Austin, TX.

Staskal, D.F., M.J. DeVito, D.G. Ross, and L.S. Birnbaum. 2003. A Comparison of the metabolism of methoxyresorufin, acetanilide, and caffeine in rat and human CYP1A2 SUPERSOMES. The Toxicologist.

Staskal, D.F., M.J. DeVito, D.G. Ross, and L.S. Birnbaum. 2003. Caffeine, Acetanilide, and Methoxyresorufin Metabolism by Rat and Human CYP1A2 SUPERSOMES and their Inhibition by 2,3,7,8,-Tetrachlorodibenzo-p-dioxin (TCDD). Organohalogen Compounds.

Grasty RC, Grey BE, Lau CS, Rogers JM. 2003. Window of susceptibility to perfluorooctane sulfonate (PFOS)-induced neonatal mortality in the rat. Birth Defects Research, Part B, 68(3), 5.

Lansita, JA, Merok, JR, and Sherley, JL. 2003. “Physicochemical Demonstration of Immortal DNA Strand Segregation,” in “Mechanisms of Toxicity, Carcinogenesis, Cancer Prevention and Cancer Therapy: Abstracts of the Seventeenth Aspen Cancer Conference,” Tox. Path., 31, 163-164.